Japan-Based Kyowa Kirin To Invest $200 Million For New Pharma Manufacturing Complex In Sanford

By Chris Capot

Japan-based specialty pharmaceutical company Kyowa Kirin has chosen Sanford in Lee County, North Carolina as the location for its first pharmaceutical manufacturing complex in North America. The company expects to create 102 new jobs and plans to invest $200m in the complex, which will manufacture Phase 2 and 3 clinical products and serve as the commercial launch site for products developed outside of the US. The project is part of a series of economic development announcements in Lee County, with other companies also committing to job creation and investment in the area. The North Carolina Department of Commerce's Economic Investment Committee has approved economic incentives worth around $2m over 12 years, adding to local incentives of about $8.7m. Keep reading to learn more about this new, innovative pharmaceutical manufacturing campus and its impact on the state.